Mutations in CASK cause a wide spectrum of phenotypes in humans ranging from mild X-linked intellectual disability to a severe microcephaly (MC) and pontocerebellar hypoplasia syndrome. 
INTRODUCTION
Microcephaly (MC) is a clinical finding defined as reduced occipitofrontal circumference (OFC) of at least 2/3 standard deviations (SD) below the mean for sex, age, and ethnicity-matched individuals. MC can be congenital (primary MC) when detected prior to 36 weeks of gestation, or develop after birth (secondary MC); in the latter case, it generally resembles dendritic or white matter disorders (Woods & Parker, 2013) . MC may present as an isolated finding or present in association with other organ malformations and/or facial dysmorphisms in the syndromic forms (Von der Hagen et al., 2014) . Despite the recent improvements in whole-exome/genome sequencing (WES/WGS) technologies and their growing application in research and diagnostic settings, a significant proportion of MC syndromes remain etiologically undefined. In addition, their phenotypic heterogeneity represents a diagnostic challenge (Rump et al., 2016) . For example, heterozygous and hemizygous aberrations in CASK (MIM# 300172) are associated with a wide phenotypic spectrum, ranging from X-linked intellectual disability with MICrocephaly and disproportionate Pontine and Cerebellar Hypoplasia (MICPCH) syndrome (MIM# 300749); to mild-severe ID with or without nystagmus (MIM# 300422); and FG syndrome 4 (MIM# 300422), characterized by ID and variable dysmorphic features such as hypotonia and constipation. CASK mutations mainly occur de novo, although maternal inheritance has been described (Moog et al., 2015; Reinstein, Tzur, Bormans, & Behar, 2016; Saitsu et al., 2012) . CASK mutations are detected typically in females.
However, affected males have been reported, and they usually display a more severe phenotype than their female counterparts. The underrepresentation of males among CASK mutation-bearing individuals is probably due to reduced male viability or lethality in utero (Moog et al., 2015; Najm et al., 2008) .
CASK was identified initially through yeast two-hybrid screening for intracellular molecules interacting with neurexins, highly polymorphic cell surface proteins involved in the formation of synaptic junctions (Hata, Butz, & Südhof, 1996) . CASK is a member of a super-family of proteins known as MAGUKs (Membrane-Associated GUanylate Kinases), multi-domain proteins characterized by the presence of a common set of structural domains that bind both polypeptide and nucleotide ligands (Kim, 1995) . CASK is composed of 3 MAGUKspecific protein domains: one PDZ (PSD-95, Discs-large, ZO-1), one SH3 (src homology 3), and a GUK (GUanylate Kinase) domain. In addition, CASK contains a calcium/calmodulin-dependent protein kinase-like domain (CaMK-like) at its N-terminus (Baines, 1996; Hata et al., 1996) , followed by two L27 (LIN-2 and LIN-7 interaction)
domains (Lee, Fan, Makarova, Straight, & Margolis, 2002) . In neurons, CASK is involved in the regulation of several processes, and each of its domains has specific binding partners with which it forms protein complexes with discrete molecular functions. For instance, at pre-synaptic sites, CASK forms a complex with MALS/Mint-1/liprin through its CaMK and L27A domains. This complex is involved in the organization of synaptic vesicle pools, thus regulating neurotransmitter release (Olsen, Moore, Nicoll, & Bredt, 2006) . Through its PDZ and SH3
domains, CASK interacts with and regulates the synaptic targeting of neurexin-1 and ion channels in a CDK5-dependent fashion (Hsueh, 2009 ). At post-synaptic termini, CASK binds to syndecan-2 via its PDZ domain and contributes to the regulation of axon branching and dendritic outgrowth (Cohen et al., 1998; Ethell & Yamaguchi, 1999) . In a SUMOylation-dependent manner, CASK connects plasma membrane proteins such as syndecan-2 to the actin cytoskeleton via protein 4.1 and spectrin, thus stabilizing dendritic spine morphology (Chao, Hong, Huang, Lin, & Hsueh, 2008) . Thus, the known versatility of CASK is likely reflected in the variable clinical presentations associated with different gene mutations (Kuo, Hong, Chien, & Hsueh, 2010; Moog et al., 2011 Moog et al., , 2015 Najm et al., 2008) .
In this study, we report the identification of previously undescribed de novo CASK mutations in four female subjects by applying WES to a cohort of undiagnosed microcephalic individuals. Additionally, we have developed a physiologically relevant zebrafish model of cask depletion, and employ in vivo complementation (Davis, Frangakis, & Katsanis, 2014; Niederriter et al., 2013) to assess variant pathogenicity. As proof of concept, we investigated the effect of three CASK variants by focusing on MC and cerebellar phenotypic readouts analogous to those commonly observed in patients with MICPCH.
MATERIALS AND METHODS

Library preparation, exome enrichment, and massive parallel sequencing
Genomic DNA was extracted from whole blood according to standard Bioanalyzer instrument (Agilent Technologies, Santa Clara, CA, USA).
The samples were then sequenced on an Illumina HiSeq2500 machine in rapid mode using a paired-end 2 × 100 bp protocol. 
Variant filtering and validation by Sanger sequencing
Trio-based filtering of annotated variants collected on an Excel file was conducted manually using "knownGene"-based annotations. 
Reverse transcription PCR
Epstein-Barr virus-immortalized lymphoblastoid cell lines (LCLs)
were established from individuals UZL6032 and UZL7743. We extracted total RNA using the RNeasy Mini Kit (Catalog #74104;
Qiagen, Hilden, Germany) according to the manufacturer's protocol.
First-strand cDNA was synthesized with oligo-dT primers using the SuperScript III First Strand Synthesis System (Catalog #18080051;
Invitrogen, Carlsbad, CA, USA) and used as template for PCR using mutation-specific primers. Bands corresponding to the canonical and alternatively spliced products were gel-excised and purified with the QIAquick Gel Extraction Kit (Catalog #28704; Qiagen, Hilden, Germany), prior to Sanger sequencing.
cDNA cloning, site-directed mutagenesis, and mRNA synthesis
The human full-length CASK cDNA was obtained from GeneCopoeia (Rockville, MD, USA) (Product ID I1396, corresponding to accession # NM_003688.3) and cloned into the pCS2+ vector using 
Zebrafish care and embryo injection
Adult zebrafish (Danio rerio) were maintained at 28.5 • C, on a 14/10 hr light/dark cycle under standard aquaculture conditions. All experiments were performed using embryos obtained from natural mating of wild-type (WT) (AB) adults. Embryos were maintained in embryo medium and staged by days post fertilization (dpf). Splice-blocking morpholinos (MOs) were designed and synthesized by GeneTools (Philomath, OR, USA) (Supp. Table S3 ). Diluted MOs and in vitro synthesized human mRNAs were injected into one-to-four cell stage embryos in a volume of 1 nl. Injected embryos were maintained at 28.5 • C and analyzed at the appropriate stage. RT-PCR on a batch of injected embryos was performed to determine the splicing efficiency of each MO compared with uninjected controls. Both canonical and the resulting alternatively spliced products were gel-excised using the QIAquick Gel Extraction Kit (Qiagen, Hilden, Germany) prior to Sanger sequencing.
Acetylated tubulin staining and imaging of zebrafish larvae
At 3 dpf, larvae were sacrificed using tricaine methane sulfonate overdose (MS-222 Cat#A5040; Sigma-Aldrich, St. Louis, MO, USA)
followed by overnight fixation in Dent's fixative (80% methanol, 20% dimethylsulfoxide). Anti-acetylated tubulin staining was performed as described (Margolin et al., 2013) . Image acquisition was performed using an Olympus BX51 fluorescence microscope equipped with a COHU 4912-5010 high performance CCD camera using an Olympus UPlan FI 10x objective. Image analysis and head size measurements were performed using ImageJ software (NIH). All experiments were repeated -two to three times; head area measurements and phenotype scoring were conducted blind to the injection cocktail on 50-60 larvae per category in each experiment.
Statistical analysis
A Kolmogorov-Smirnov test (XLSTAT-free software) was used to evaluate whether the head area datasets were normally distributed; since the data distribution was not normal, the nonparametric MannWhitney's two-tailed test (alpha 0.05) was used to compare morphometric data from zebrafish larval batches following MO and mRNAs injections. Chi-squared tests were calculated using an online interactive tool (https://statpages.info/chisq.html) and used to evaluate differences in cerebellar phenotype proportions (alpha 0.01).
RESULTS
WES reveals novel CASK mutations
We evaluated three affected females who presented with sporadic postnatal progressive MC with profound ID and delayed psychomotor development (Table 1) . Their ages ranged between 17 months to 25 years at last clinical follow-up. OFC at birth was within the normal range for three cases, but for the fourth OFC corresponded to −2 SD (31.5 cm). Birth length was also in the normal range for all four females (+0.6/−1.1 SD). At last assessment, OFC was significantly reduced in all individuals (−3.6/−6.6 SD), whereas length was mildly below average (−1.1/−3.1 SD). Brain imaging did not reveal clear abnormalities in two patients, whereas one had cerebellar hypoplasia.
One patient presented with osteosynthesis material in the cervical spine, hence brain imaging could not be performed. Three of four affected individuals displayed neurological abnormalities such as severe hypotonia, tetraspasticity, and stiff gait. Only one girl showed a minor facial dysmorphism (hypotelorism and low-set ears). Furthermore, three of four cases also exhibited ophthalmologic anomalies (strabismus, nystagmus) and visual impairment.
Molecular karyotyping was performed in all four affected individuals but no pathogenic copy number variations (CNVs) were found.
We then performed WES on each case and their respective parents when possible (available for three of four cases). Trio-based filtering was conducted primarily under a de novo inheritance paradigm based on the known sporadic nature of the observed phenotypes.
Parental WES was not performed for individual UZL7743, who was the product of a heterologous in vitro fertilization procedure; in this case, we screened for rare damaging variants in a literature-based list of genes known to be associated with MC, ID, and developmental delay (DD). After massive parallel sequencing, we obtained on average 87.5 million total reads per exome (between 65.1 and 112.8 million), and ∼90% of reads passed filter quality thresholds and mapped and Supp. Table S2 ). Except for the c.626T > C allele which is already described in ClinVar (Accession RCV000498072.1), these variants are absent from population databases [gnomAD, NHLBI Exome Variant Server (EVS), Leiden Open Variation Database, Kaviar, dbSNP147, and
1000Genomes Project], and from the in-house developed database NGS Logistics (Ardeshirdavani et al., 2014) . Besides the two variants located in intronic regions near splicing sites for which damage prediction values were not available, both missense p.Leu209Pro and nonsense p.Gln37* mutations were assessed concordantly to be possibly or probably pathogenic by multiple in silico damage prediction tools (Supp. Table S2 ). Absence of the novel mutations in the respective biological parental couples was confirmed further by Sanger sequencing in all four cases (Supp. Figure S1 ).
To determine the effect of the intronic variants (c.2302+1G > A and c.1315-7A > G) on mRNA splicing, we extracted total mRNA from patient-derived LCLs and monitored splicing products. We reverse transcribed LCL-derived mRNA, and used it as template for PCR amplification with primers located on exons surrounding each mutation site (Supp . Table S3 ). In contrast to control, the c.2302+1G > A variant resulted in two distinct PCR products as evidenced by agarose gel electrophoresis ( Figure 1B ). Gel purification and Sanger sequencing revealed that the larger product corresponded to the canonical transcript while the lower alternative band was the product of exon 24 skipping (NP_003679.2: p.Gly741_His768delinsAsp).
To determine the effect of the c.1315-7A > G variant, we first performed an in silico splicing analysis of both canonical and mutationcontaining sequences using the Human Splicing Finder (HSF) v.3.0 tool (Desmet et al., 2009 ). Introduction of the de novo variant was predicted to disrupt an enhancer splice site and to generate a novel 
In vivo analysis of CASK variants in developing zebrafish
To establish a rapid assay that could distinguish between hypomorphic and severely damaging CASK point mutations and to possibly identify more detailed genotype-phenotype correlations, we developed a transient zebrafish CASK suppression model. We employed this model to investigate two MICPCH characterizing traits in particular: MC and cerebellar defects. Both clinical features have been employed previously in the evaluation of candidate genes for neurocognitive disorders (Beunders et al., 2013; Borck et al., 2015) . Previous genotypephenotype observations hypothesized that females with hypomorphic CASK mutations display a milder phenotype compared with those bearing severely disrupting variants (Burglen et al., 2012; Moog et al., 2011 Moog et al., , 2015 . Two of our cases displayed point mutations, namely the missense CaMK domain p.Leu209Pro and the early truncating p.Gln37*. Figure S2B and D).
To assess phenotypes relevant to MC, we first tested the effect of each MO on 3 dpf larval head-size by measuring the area between the eyes (Figure 2A-F) . Compared with controls, we achieved a ∼10% reduction in head size with caska sb-MOs (8 ng, E2I2: 92% and E7I7:
91%, P = 0.0005 and <0.0001, respectively) and a 13% reduction for caskb knock-down (8 ng, P < 0.0001) (Supp. Figure S2E ). Next, we established specificity of the phenotype by coinjection of either sb-MO with WT human mRNA ( Figure 2G and H). For caska, we performed rescues using the E7I7 sb-MO which appeared to be more efficient on RT-PCR (Supp. Figure S2A ) and with a more significant dose-dependent effect compared with the E2I2 MO (Supp. Figure S2E) . We rescued the MC phenotype with 150 pg of WT human mRNA in both caska (95%, P = 0.052) and caskb (97%, P = 0.34) morphants such that they were indistinguishable from controls.
To further confirm specificity and to possibly observe phenotypic changes associated to the different type of variants, we performed in vivo complementation studies for both caska and caskb morphants with mRNA containing the point mutations of interest. We included a positive control for our zebrafish assays, the pathogenic nonsense p.Arg639* variant (rs137852815) (Najm et al., 2008) , which should F I G U R E 2 Average head size of caska and caskb morphant zebrafish and mRNA rescues. A-F: Representative images of uninjected controls, caska E7I7 morphants, WT and mutant mRNA rescue larvae at 3 dpf. The head area measured (inside the white lines) comprises forebrain and midbrain regions between the eyes (scale bar: 100 m). G: caska E7I7 MO and H: caskb E20I20 MO coinjected with 150 pg of either WT or mutant mRNAs. Error bars represent standard deviation. Tables below the graphs: Mann-Whitney test ***P ≤ 0.0001; **0.0001 < P ≤ 0.001; *0.001 < P < 0.05; not significant (ns), P ≥ 0.05 fail to rescue head size phenotypes for either MO. In vivo testing of all three mutant alleles resulted in head size defects comparable to the effect of both caska and caskb MOs alone, although p.Gln37* exerted a slightly more severe effect (P = 0.003 and 0.02 vs. caska and caskb MOs, respectively). We observed modestly different effects of the mutant alleles compared with WT for the caska MO rescue experiments ( Figure 2G ) with the p.Gln37* being the most significantly different from WT rescue (P < 0.0001), followed by the pathogenic p.Arg639* (P = 0.0026; positive control variant) and missense p.Leu209Pro (P = 0.019). However, for caskb MO rescues, the three mutant alleles were equally damaging compared with the WT allele rescue ( Figure 2H , P < 0.0001).
Next, we used the morphant model to investigate the cerebellar phenotype associated with CASK mutations. We performed anti acetylated tubulin staining on 3 dpf larvae to mark axon tracts ( Figure 3A) and scored them according to the organization and integrity of the cerebellar structure as normal (symmetric and intact corpus cerebelli, with dense and intact axon tracts across the midline), moderately affected (intact corpus cerebelli with reduction or absence of axon tracts across the midline), and severely affected (hypoplastic corpus cerebelli with absent axon tracts across the midline, agenesis) (Margolin et al., 2013) . caska and caskb sb-MOs caused marked cerebellar defects in 48.7% and 61.1% of larvae, respectively, compared with less than 5%-7% of uninjected controls ( Figure 3B and C 
DISCUSSION
In a whole exome screen of cases with syndromic MC, we identified four novel CASK mutations. The same consequence was demonstrated in an individual carrying a de novo c.2302+5 G > A variant (Burglen et al., 2012) . For the other three individuals, the splicing effect was not determined (Hayashi et al., 2017; Rump et al., 2016; Takanashi et al., 2012 ), but we suspect it to be identical to the other two cases. Besides two individuals for which clinical data were scarce, the other two presented severe ID/DD, brain defects, spasticity and ophthalmologic abnormalities. The affected female from our cohort did not present such a severe phenotype. Considering her young age though, her clinical course might deteriorate, although a wide variability in clinical phenotype has been observed even among cases with variants predicted to have similar effects on protein functionality (Dunn et al., 2017) .
In our cohort, three girls showed ophthalmologic anomalies and two of them specifically displayed nystagmus. Previous reports have indicated that congenital nystagmus is strongly associated with mutations localized in the GUK domain of CASK (Dunn et al., 2017; Hackett et al., 2010; Watkins et al., 2013) . This domain interacts with FRMD7, a plasma membrane-cytoskeleton coupling protein, mutations of which cause X-linked congenital nystagmus (Tarpey et al., 2006) . Nystagmus was present in the individual with the p.Gly741_His768delinsAsp mutation, involving the initial part of GUK domain. However, this feature was also present in the girl carrying the p.Leu209Pro variant, located in the CaMK domain of the protein. We cannot exclude that this missense mutation might affect the protein structure. For example, it has been shown that the p.Arg28Leu variant alters the splicing machinery, resulting in an out-of-frame exon 2-skipped transcript as a consequence of an altered recognition of Exonic Splicing Enhancer motifs (Piluso et al., 2008) . Nystagmus has not been observed in individuals with CASK nonsense mutations or gene-disrupting CNVs, and was absent in our two cases carrying pre-GUK terminating mutations.
This observation suggests that the absence of the GUK domain may not be a sufficient condition for the development of nystagmus in these affected individuals, as could however be the aberrant FRMD7/CASK interaction caused by mutations altering GUK structure and functionality.
There are a few modest discrepancies in the severity of the cerebellar phenotype observed in caska and caskb complementation assays (Supp . Table S5 ). This is possibly due to different effects of the MOs employed in these assays, which may not cause a reduced protein expression via nonsense mediated decay, but rather generate shorter alternative proteins with novel functions. Our aim though was not to investigate the different functions of caska and caskb in zebrafish.
Nonetheless, we propose that the two genes are not functionally redundant given that microcephalic and cerebellar phenotypes were evident in both caska and caskb morphants individually. Comparing our results with those resulting from coinjecting both caska and caskb MOs could elucidate a putative functional divergence between the two paralogs. In addition, the generation of caska and caskb mutants using genome editing would be beneficial to strengthen our findings.
In conclusion, we identified four novel mutations in CASK as the cause of syndromic MC and used the zebrafish model to evaluate differences in cerebellar phenotype and head size by complementation assays using different types of point mutations, thus highlighting the possibility to establish a tractable pipeline to screen novel CASK variants in the future. Since CASK interacts with several proteins through its different protein domains, the generation of constructs bearing mutations interrupting a specific protein-protein interaction would be useful to elucidate their individual physiological significance on brain development and synapse maintenance (Huang & Hsueh, 2009 ).
In addition, comparison of rare variants both within the CASK locus as well as the genomic background across affected individuals will prove critical toward elucidating phenotype-genotype correlations for CASK-associated disorders.
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